Preparing for Your Targeted Treatment in the Clinic

Read article

Rescuing an Oncology Study in the U.S.

When startup biotech or pharma companies are conducting…
Read Article

CAR T-Cell Therapies – Now Targeting Solid Tumors

Most in oncology drug development are aware of…
Read Article

How to Avoid Missing Patient Enrollment Targets in Your First Oncology Study

It’s common for sponsors to miss their patient…
Read Article

Cancer Vaccines – Promising Research Gets Closer to Reality

Vaccines are at the top of everyone’s mind…
Read Article

Selecting a CRO During the COVID-19 Pandemic

In 2014, we wrote a popular post about…
Read Article

Tips for Bringing Your First Oncology Drug into the Clinic in the United States

While cancer is a global health challenge, the…
Read Article

FDA Guidance on Conduct of Clinical Trials During COVID-19

These are challenging times, as the world grapples…
Read Article

Preparing for Your Phase I Oncology Study

The phase 1 study is the gateway between…
Read Article

Managing the Side Effects in a CAR T-cell Therapy Study

CAR T-cell therapy, together with checkpoint inhibition, has…
Read Article